132 related articles for article (PubMed ID: 32941875)
1. Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms.
Miller S; Daily L; Ploss M; Greig I; Ross R; Rayana NP; Dai J; Sugali CK; Mao W; Straiker A
Exp Eye Res; 2020 Nov; 200():108241. PubMed ID: 32941875
[TBL] [Abstract][Full Text] [Related]
2. The In Vivo Effects of the CB
Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM
J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234
[TBL] [Abstract][Full Text] [Related]
3. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
Miller S; Daily L; Leishman E; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5904-5911. PubMed ID: 30550613
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure.
Miller S; Daily L; Dharla V; Gertsch J; Malamas MS; Ojima I; Kaczocha M; Ogasawara D; Straiker A
Exp Eye Res; 2020 Dec; 201():108266. PubMed ID: 32979397
[TBL] [Abstract][Full Text] [Related]
5. A GPR18-based signalling system regulates IOP in murine eye.
Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
[TBL] [Abstract][Full Text] [Related]
6. Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure.
Miller S; Kulkarni S; Ciesielski A; Nikas SP; Mackie K; Makriyannis A; Straiker A
Pharmaceuticals (Basel); 2018 May; 11(2):. PubMed ID: 29786643
[TBL] [Abstract][Full Text] [Related]
7. Elevated intraocular pressure increases melatonin levels in the aqueous humour.
Alkozi H; Sánchez-Naves J; de Lara MJ; Carracedo G; Fonseca B; Martinez-Aguila A; Pintor J
Acta Ophthalmol; 2017 May; 95(3):e185-e189. PubMed ID: 27595784
[TBL] [Abstract][Full Text] [Related]
8. An effective prodrug strategy to selectively enhance ocular exposure of a cannabinoid receptor (CB1/2) agonist.
Mainolfi N; Powers J; Amin J; Long D; Lee W; McLaughlin ME; Jaffee B; Brain C; Elliott J; Sivak JM
J Med Chem; 2013 Jul; 56(13):5464-72. PubMed ID: 23738526
[TBL] [Abstract][Full Text] [Related]
9. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
[TBL] [Abstract][Full Text] [Related]
10. A GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex-Dependent Manner.
Miller S; Hu SS; Leishman E; Morgan D; Wager-Miller J; Mackie K; Bradshaw HB; Straiker A
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2930-2938. PubMed ID: 28593245
[TBL] [Abstract][Full Text] [Related]
11. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure.
Miller S; Leishman E; Oehler O; Daily L; Murataeva N; Wager-Miller J; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6419-6426. PubMed ID: 27893106
[TBL] [Abstract][Full Text] [Related]
13. Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice.
Millar JC; Savinainen A; Josiah S; Pang IH
Exp Eye Res; 2019 Nov; 188():107763. PubMed ID: 31421135
[TBL] [Abstract][Full Text] [Related]
14. Acetaminophen Relieves Inflammatory Pain through CB
Klinger-Gratz PP; Ralvenius WT; Neumann E; Kato A; Nyilas R; Lele Z; Katona I; Zeilhofer HU
J Neurosci; 2018 Jan; 38(2):322-334. PubMed ID: 29167401
[TBL] [Abstract][Full Text] [Related]
15. eNOS, a pressure-dependent regulator of intraocular pressure.
Stamer WD; Lei Y; Boussommier-Calleja A; Overby DR; Ethier CR
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9438-44. PubMed ID: 22039240
[TBL] [Abstract][Full Text] [Related]
16. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
[TBL] [Abstract][Full Text] [Related]
17. Melatonin and the control of intraocular pressure.
Alkozi HA; Navarro G; Franco R; Pintor J
Prog Retin Eye Res; 2020 Mar; 75():100798. PubMed ID: 31560946
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Intraocular-Pressure-Lowering Therapy Targeting ATX.
Nagano N; Honjo M; Kawaguchi M; Nishimasu H; Nureki O; Kano K; Aoki J; Komatsu T; Okabe T; Kojima H; Nagano T; Aihara M
Biol Pharm Bull; 2019; 42(11):1926-1935. PubMed ID: 31685776
[TBL] [Abstract][Full Text] [Related]
19. Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.
Oltmanns MH; Samudre SS; Castillo IG; Hosseini A; Lichtman AH; Allen RC; Lattanzio FA; Williams PB
J Ocul Pharmacol Ther; 2008 Feb; 24(1):104-15. PubMed ID: 18201139
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
Álvaro-Bartolomé M; García-Sevilla JA
Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
